Related Experiment Video
Updated: May 30, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
[Treatment of systemic sclerosis]
Gabriel Medrano Ramírez1, Olga Lidia Vera-Lastra, Luis J Jara
1Departamento de Reumatología. Hospital General de México. SS. México DF. México.
Reumatologia Clinica
|July 29, 2011
Summary
Systemic sclerosis treatments target vascular damage, fibrosis, and immune responses. While vascular issues show promise, antifibrotic therapies and immunosuppressants like cyclophosphamide offer potential benefits.
Area of Science:
- Rheumatology
- Immunology
- Vascular Medicine
Context:
- Systemic sclerosis (SSc) management involves addressing its complex multi-organ manifestations.
- Current therapeutic approaches target vascular, fibrotic, and immune system components.
Purpose:
- To review current treatment strategies for systemic sclerosis.
- To evaluate the efficacy of different drug classes in managing SSc symptoms and complications.
Summary:
- Vascular damage in SSc, including Raynaud's phenomenon, renal crisis, and pulmonary arterial hypertension, is effectively managed by drugs like calcium antagonists and endothelin receptor blockers.
- Antifibrotic agents have shown limited success, with D-penicillamine remaining controversial.
- Immunosuppressive therapies, such as cyclophosphamide and hematopoietic stem cell transplantation, may offer benefits.
Impact:
- Highlights the need for improved antifibrotic treatments for systemic sclerosis.
- Emphasizes the potential of understanding SSc pathogenesis at a molecular level to develop novel therapeutic strategies.
- Informs clinicians about current treatment options and their varying efficacies in managing SSc.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...